The Economic Burden of Prostate Cancer Survivorship Care

In Medicare beneficiaries the prostate cancer continuing care phase is associated with substantial variation, resulting in potentially unnecessary excess cost to the health care system. Variation was evident across the spectrum of disease severity and implies the need for better evidence to inform clinical practice.